Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012

Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012–2014

Published:2019-02-08 Issue:6 Volume:26 Page:1604-1612
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Mallin Katherine,Browner Amanda,Palis Bryan,Gay Greer,McCabe Ryan,Nogueira Leticia,Yabroff Robin,Shulman Lawrence,Facktor Matthew,Winchester David P.,Nelson Heidi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-019-07213-1/fulltext.html

Reference12 articles.

1. Steele GD, Winchester DP, Menck, HR. The National Cancer Data Base. Cancer. 1994;73:499–504.

2. American College of Surgeons. National Cancer Database. Retrieved 11 July 2018 at https://www.facs.org/quality-programs/cancer/ncdb .

3. Bilimoria K, Stewart AK, Winchester DP, Ko, CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683–90.

4. Lerro CC, Robbins AS, Phillips JL, Stewart AK. Comparison of cases captured in the National Cancer Data Base with those in population-based Central Cancer Registries. Ann Surg Oncol. 2013;20:1759–65.

5. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GA, 2017. Retrieved 26 July 2018 at www.cdc.gov/uscs .

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer;Annals of Surgical Oncology;2024-09-09

2. Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2024-09-04

3. Increase in Hypofractionated Radiation Therapy Among Patients with Invasive Breast Cancer or Ductal Carcinoma In Situ: Who is Left Behind?;Practical Radiation Oncology;2024-09

4. Management of patients with liver-confined, synchronous metastatic breast cancer;Surgical Oncology Insight;2024-09

5. Clinical Outcomes and Efficacy of Human Epidermal Growth Factor Receptor 2–Targeted Therapy in Breast Cancer With Uncommon In Situ Hybridization Patterns or Discordant Immunohistochemistry;JCO Oncology Advances;2024-09